Kymera Therapeutics, Inc. (KYMR) › EPS (Basic)Kymera Therapeutics, Inc. (KYMR) — EPS (Basic)Annual figures by period end, from SEC filings.2020-12-31: $-3.152021-12-31: $-2.092022-12-31: $-2.872023-12-31: $-2.522024-12-31: $-2.982025-12-31: $-3.69$-3.692020-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-3.69—2026-02-26From 2025-01-012024-12-31$-2.98—2026-02-26From 2024-01-012023-12-31$-2.52—2026-02-26From 2023-01-012022-12-31$-2.87—2025-02-27From 2022-01-012021-12-31$-2.09—2024-02-22From 2021-01-012020-12-31$-3.15—2023-02-23From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares